(Q37628704)

21 August 2017

1 reference

title

Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme (English)

1 reference

adaptive radiation therapy

21 August 2017

main subject

0 references

1 reference

Cormac Small

3

0 references

author name string

Wilson Roa

1

1 reference

21 August 2017

James Z Xing

2

1 reference

21 August 2017

Rolf Kortmann

4

1 reference

21 August 2017

Rene Miriamanoff

5

1 reference

21 August 2017

Paul Okunieff

6

1 reference

21 August 2017

Yuta Shibamoto

7

1 reference

21 August 2017

Branislav Jeremic

8

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Expert Review of Anticancer Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1643-1650

1 reference

Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Brain tumor survival: results from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Adult glioma incidence trends in the United States, 1977-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Trials in palliative treatment--have the goal posts been moved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Treating recurrent cases of squamous cell carcinoma with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Participation of patients 65 years of age or older in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Patterns of care in elderly glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Efficacy of radiotherapy for malignant gliomas in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Hypofractionation in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

A prospective study on glioblastoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Cancer in the developing world: a call to action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Multinational assessment of some operational costs of teletherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Radiation therapy in Africa: distribution and equipment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Role of radiotherapy in cancer control in low-income and middle-income countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Quantitative status of resources for radiation therapy in Asia and Pacific region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

A prospective study of short course radiotherapy in elderly patients with malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Glioblastoma in the older patient: how long a course of radiotherapy is necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.128

21 January 2018

Identifiers

DOI

10.1586/ERA.09.128

1 reference

21 August 2017

1 reference